Other OTC Pharmaceuticals (Pharmacies) - Luxembourg

  • Luxembourg
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$6.37m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.17%, resulting in a market volume of US$6.75m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$9.64 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Luxembourg has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Luxembourg have shifted towards a greater emphasis on self-care and preventive healthcare. Consumers are increasingly taking a proactive approach to their health, seeking out over-the-counter medications to manage minor ailments and maintain overall well-being. This trend is driven by a growing awareness of the benefits of self-medication, as well as a desire for convenience and cost-effectiveness. Trends in the market reflect this shift towards self-care. Pharmacies in Luxembourg have responded by expanding their offerings of over-the-counter medications, including a wide range of products for common conditions such as cold and flu, allergies, and digestive issues. In addition, pharmacies have invested in staff training and education to provide customers with expert advice on self-medication and preventive healthcare. This emphasis on customer service and expertise has helped to differentiate pharmacies from other retail channels, further driving growth in the market. Local special circumstances in Luxembourg have also contributed to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a well-established healthcare system that places a strong emphasis on accessibility and quality of care. Pharmacies play a crucial role in this system, serving as a primary point of contact for healthcare services and advice. As a result, pharmacies in Luxembourg enjoy a high level of trust and credibility among consumers, which has further fueled the demand for over-the-counter medications. Underlying macroeconomic factors have also played a role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Luxembourg. The country has a high per capita income and a strong economy, which has translated into increased disposable income and healthcare spending. As consumers have become more health-conscious and willing to invest in self-care, they have been willing to spend more on over-the-counter medications. Additionally, the aging population in Luxembourg has contributed to the demand for over-the-counter medications, as older individuals are more likely to require medication for chronic conditions and age-related ailments. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Luxembourg is developing due to shifting customer preferences towards self-care, trends in the market that emphasize a wider range of over-the-counter medications and expert advice, local special circumstances that prioritize accessibility and quality of care, and underlying macroeconomic factors such as high disposable income and an aging population. This growth is expected to continue as consumers continue to prioritize their health and well-being.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)